Luminopia
Cambridge
About Luminopia
Luminopia develops a new class of treatments for significant neuro-visual disorders. The company is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, to treat amblyopia, the cause of vision loss among children.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $33.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: luminopia.com
- Phone: 1 833-458-6466
Industries & Categories
Health Care, Medical, Neuroscience, Virtual Reality
Social Profiles
Canonical: https://fsome.com/organization/luminopia-26475 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.